Last edition
News about
This two-days event will focus on exploring pharma and healthcare industry current position and their future in light of novel approaches and capabilities beyond the pandemic. BioAsia 2022 platform will be shared by leaders from the industry, academia, and governments from more than 70 countries to address the wide-ranging needs of the healthcare system
Powder formulas, Similac, Alimentum & EleCare manufactured at Michigan plant are recalled by Abbott
Abbott is voluntarily recalling these products after four consumer complaints related to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility
To enhance lab productivity, Agilent acquires AI technology
Agilent will integrate the software, known as ACIES, into its industry-leading Gas Chromatography and Mass Spectrometry (GS/MS) platforms to improve the productivity, efficiency and accuracy of high-throughput labs the company serves around the world
The full integration of drug substance R&D and manufacturing follows a year after the company's acquisition of its Alnwick, UK site and provides a more streamlined approach from candidate selection through to commercialization. Quotient Sciences Translational Pharmaceutics approach combining manufacturing and clinical dosing at a single organization
The US Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has formally granted Orphan Drug Designation (ODD) to Innovent Biologics's fully-human B-Cell Maturation Antigen (BCMA)-targetted Chimeric Antigen Receptor (CAR) T-cell therapy
The GTAEC is an independent body of experts representing diverse areas of biomedical research, concerned government agencies and other stakeholders constituted and notified by the department of health research, Union ministry of health and family welfare to oversee the activities in the field of gene therapy research in India
In the past 12 months, Velocity has randomized 25,000 patients into phase II and III studies in the US. The tech investments will enable Velocity to be more efficient in managing studies, identifying patients for studies, and increasing the frequency of participation in studies
Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease. The market for this category is valued at ~ Rs. 900 crore growing at 14% (IQVIA). The acquisition of Combihale is expected to strengthen Mankind's presence in the inhalation respiratory market segment
The deadline for voluntary registration of Class A and Class B medical devices with the regulator ended on September 30, 2021 and registration became compulsory from October 1, 2021. Manufacturers are required to complete mandatory registration with the CDSCO by September 30, 2022. It has come to the notice that a significant number
JB Chemicals and Pharmaceuticals: revenue growth of 10 per cent
JB Chemicals and Pharmaceuticals has announced its financial results for the third quarter ended 31st December, 2021. For the third quarter ended 31st December, 2021, the company recorded revenue of Rs 601 crores as compared to Rs 548 crores, registering a growth of 10 per cent over the corresponding quarter of the previous financial year
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy